NASDAQ:BRLI - Bio-Reference Laboratories Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Bio-Reference Laboratories, Inc. is a clinical testing laboratory, which offers testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. The Company offers a range of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. It is focused on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional health care. It offers a list of chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology services, serology, radio-immuno analysis, toxicology and other tissue analysis. It operates a clinical knowledge management service through its PSIMedica business unit. It also operates a Web-based connectivity portal solution for laboratories and physicians through its CareEvolve subsidiary. Its laboratory testing business consists of routine testing and esoteric testing.

Receive BRLI News and Ratings via Email

Sign-up to receive the latest news and ratings for BRLI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Services
SectorN/A
Current SymbolNASDAQ:BRLI
CUSIP09057G60
Phone+1-201-7912186

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
OptionableNot Optionable

Bio-Reference Laboratories (NASDAQ:BRLI) Frequently Asked Questions

What is Bio-Reference Laboratories' stock symbol?

Bio-Reference Laboratories trades on the NASDAQ under the ticker symbol "BRLI."

How were Bio-Reference Laboratories' earnings last quarter?

Bio-Reference Laboratories Inc (NASDAQ:BRLI) issued its earnings results on Thursday, December, 18th. The medical research company reported $0.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.63 by $0.03. The medical research company earned $227.60 million during the quarter, compared to analysts' expectations of $228.81 million. The firm's quarterly revenue was up 18.4% on a year-over-year basis. During the same period last year, the firm posted $0.40 earnings per share. View Bio-Reference Laboratories' Earnings History.

Has Bio-Reference Laboratories been receiving favorable news coverage?

Headlines about BRLI stock have been trending somewhat negative this week, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Bio-Reference Laboratories earned a coverage optimism score of -1.7 on InfoTrie's scale. They also assigned news coverage about the medical research company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near future.

How do I buy shares of Bio-Reference Laboratories?

Shares of BRLI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bio-Reference Laboratories' official website?

The official website for Bio-Reference Laboratories is http://www.bioreference.com.

How can I contact Bio-Reference Laboratories?

Bio-Reference Laboratories' mailing address is 481 Edward H Ross Dr, ELMWOOD PARK, NJ 07407-3118, United States. The medical research company can be reached via phone at +1-201-7912186.


MarketBeat Community Rating for Bio-Reference Laboratories (NASDAQ BRLI)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  92 (Vote Outperform)
Underperform Votes:  81 (Vote Underperform)
Total Votes:  173
MarketBeat's community ratings are surveys of what our community members think about Bio-Reference Laboratories and other stocks. Vote "Outperform" if you believe BRLI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BRLI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/21/2019 by MarketBeat.com Staff

Featured Article: Discount Rate

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel